Garrett Hamontree
Finanzdirektor/CFO bei Visionary Ventures Management LLC
Profil
Garrett Hamontree is currently a Principal at Visionary Ventures Management LLC since 2019.
He is also a Board Member at Re-Vana Therapeutics Ltd.
since 2020.
Previously, he served as the Chief Executive Officer & Board Member at Bridgemark Corp.
from 2015 to 2016.
Mr. Hamontree completed his undergraduate degree at Vanderbilt University in 2012 and obtained an MBA from USC Marshall School of Business in 2018.
Aktive Positionen von Garrett Hamontree
| Unternehmen | Position | Beginn |
|---|---|---|
Visionary Ventures Management LLC
 Visionary Ventures Management LLC Investment ManagersFinance Visionary Ventures Management LLC (Visionary Ventures) is a venture capital firm founded in 2016 by Ehsan Sadri. The firm is headquartered in Aliso Viejo, California. | Finanzdirektor/CFO | 01.06.2019 |
Re-Vana Therapeutics Ltd.
 Re-Vana Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Re-Vana Therapeutics Ltd. is a specialty ocular therapeutic and British drug delivery company that focuses on developing its internal pipeline and external strategic collaborations to advance its novel drug delivery platform. In 2022, Re-Vana won the Ophthalmic Innovation Summit Retina Award in drug delivery and the Belfast Nth Ireland Chamber 2022 Award for Business Innovation. Re-Vana Therapeutics was founded in 2016 as a spin-out from Queen's University, with the main office located in Belfast, UK, and an office, Re-Vana Therapeutics, Inc., based elsewhere. The company has raised more than $17.75m to support the development of sustained release biologics. In 2019, Re-Vana secured funding from Innovate totaling more than $400k to support the development of a sustained release drug. Additionally, in 2020, the company entered into a strategic feasibility collaboration with a leading pharmaceutical company for a novel therapeutic. | Direktor/Vorstandsmitglied | 01.06.2020 |
Ehemalige bekannte Positionen von Garrett Hamontree
| Unternehmen | Position | Ende |
|---|---|---|
| Bridgemark Corp. | Vorstandsvorsitzender | 01.07.2016 |
Ausbildung von Garrett Hamontree
| Vanderbilt University | Undergraduate Degree |
| USC Marshall School of Business | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
| Bridgemark Corp. | |
Visionary Ventures Management LLC
Visionary Ventures Management LLC Investment ManagersFinance Visionary Ventures Management LLC (Visionary Ventures) is a venture capital firm founded in 2016 by Ehsan Sadri. The firm is headquartered in Aliso Viejo, California. | Finance |
Re-Vana Therapeutics Ltd.
Re-Vana Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Re-Vana Therapeutics Ltd. is a specialty ocular therapeutic and British drug delivery company that focuses on developing its internal pipeline and external strategic collaborations to advance its novel drug delivery platform. In 2022, Re-Vana won the Ophthalmic Innovation Summit Retina Award in drug delivery and the Belfast Nth Ireland Chamber 2022 Award for Business Innovation. Re-Vana Therapeutics was founded in 2016 as a spin-out from Queen's University, with the main office located in Belfast, UK, and an office, Re-Vana Therapeutics, Inc., based elsewhere. The company has raised more than $17.75m to support the development of sustained release biologics. In 2019, Re-Vana secured funding from Innovate totaling more than $400k to support the development of a sustained release drug. Additionally, in 2020, the company entered into a strategic feasibility collaboration with a leading pharmaceutical company for a novel therapeutic. | Health Technology |